Literature DB >> 15047745

Steatosis and fibrosis in patients with chronic hepatitis C.

J Wyatt1, H Baker, P Prasad, Y Y Gong, C Millson.   

Abstract

BACKGROUND: Steatosis is present on liver biopsy in approximately 50% of patients with hepatitis C; its association with stage of fibrosis has been reported, but its relation to other fibrosis associated factors is unknown. AIM: To study the relation between steatosis and other histological features in patients with hepatitis C, and changes in steatosis with time.
METHODS: Cross sectional study: 233 routine liver biopsies from 219 patients with hepatitis C; hepatectomy specimens from 65 patients transplanted for hepatitis C cirrhosis. Longitudinal study: 41 patients with two biopsies and 10 patients with three biopsies performed over 2-8 years. Biopsies were scored by the Ishak scheme, and degree of steatosis assessed subjectively. Multivariate analysis was used to study the interaction of fibrosis associated factors. Changes in steatosis over time in individual patients were explored in the longitudinal study.
RESULTS: Steatosis was present in 50% of biopsies. It correlated strongly with fibrosis in non-cirrhotic samples, but declined in cirrhosis, and was unusual in transplant hepatectomy specimens. On multivariate analysis of non-cirrhotic biopsies, steatosis was associated with increasing patient age and remained significantly associated with fibrosis independent of portal inflammation and interface hepatitis. In the longitudinal study, steatosis persisted and increased over time, except in patients developing cirrhosis.
CONCLUSIONS: Steatosis is associated with fibrosis independently of necroinflammation, but declines in cirrhosis. It may represent a pathogenic pathway distinct from necroinflammatory activity in the generation of liver fibrosis, and should be included in the assessment of biopsies for clinical and research purposes.

Entities:  

Mesh:

Year:  2004        PMID: 15047745      PMCID: PMC1770262          DOI: 10.1136/jcp.2003.009357

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  26 in total

Review 1.  Chronic hepatitis C: grading, staging, and searching for reliable predictors of outcome.

Authors:  G K Koukoulis
Journal:  Hum Pathol       Date:  2001-09       Impact factor: 3.466

2.  Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

Authors:  L Rubbia-Brandt; R Quadri; K Abid; E Giostra; P J Malé; G Mentha; L Spahr; J P Zarski; B Borisch; A Hadengue; F Negro
Journal:  J Hepatol       Date:  2000-07       Impact factor: 25.083

3.  Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.

Authors:  L E Adinolfi; M Gambardella; A Andreana; M F Tripodi ; R Utili; G Ruggiero
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

4.  Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3.

Authors:  L Rubbia-Brandt; G Leandro; L Spahr; E Giostra; R Quadri; P J Malé; F Negro
Journal:  Histopathology       Date:  2001-08       Impact factor: 5.087

5.  Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C.

Authors:  H Fontaine; B Nalpas; B Poulet; F Carnot; H Zylberberg; C Brechot; S Pol
Journal:  Hum Pathol       Date:  2001-09       Impact factor: 3.466

6.  Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.

Authors:  L E Adinolfi; R Utili; A Andreana; M F Tripodi; M Marracino; M Gambardella; M Giordano; G Ruggiero
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

7.  Detection of the negative-strand hepatitis C virus RNA in tissues: implications for pathogenesis.

Authors:  R Quadri; L Rubbia-Brandt; K Abid; F Negro
Journal:  Antiviral Res       Date:  2001-11       Impact factor: 5.970

8.  Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

Authors:  T Poynard; P Bedossa; P Opolon
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

9.  Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.

Authors:  J M Petit; J B Bour; C Galland-Jos; A Minello; B Verges; M Guiguet; J M Brun; P Hillon
Journal:  J Hepatol       Date:  2001-08       Impact factor: 25.083

10.  Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C.

Authors:  I J Hickman; A D Clouston; G A Macdonald; D M Purdie; J B Prins; S Ash; J R Jonsson; E E Powell
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

View more
  10 in total

1.  Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis.

Authors:  Paolo Sorrentino; Luigi Terracciano; Salvatore D'Angelo; Umberto Ferbo; Alessandra Bracigliano; Luciano Tarantino; Alessandro Perrella; Oreste Perrella; Giovanni De Chiara; Luigi Panico; Noè De Stefano; Mariolina Lepore; Raffaela Vecchione
Journal:  J Gastroenterol       Date:  2010-10       Impact factor: 7.527

2.  Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.

Authors:  Anna S Lok; James E Everhart; Raymond T Chung; Hae-Young Kim; Gregory T Everson; John C Hoefs; Joel K Greenson; Richard K Sterling; Karen L Lindsay; William M Lee; Adrian M Di Bisceglie; Herbert L Bonkovsky; Marc G Ghany; Chihiro Morishima
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

3.  Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.

Authors:  James E Everhart; Anna S Lok; Hae-Young Kim; Timothy R Morgan; Karen L Lindsay; Raymond T Chung; Herbert L Bonkovsky; Marc G Ghany
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

Review 4.  Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen.

Authors:  Amedeo Lonardo; Luigi Elio Adinolfi; Luciano Restivo; Stefano Ballestri; Dante Romagnoli; Enrica Baldelli; Fabio Nascimbeni; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

5.  Prognostic factors for progression of liver structural lesions in chronic hepatitis C patients.

Authors:  Liliana S C Mendes; Marcelo E Nita; Suzane K Ono-Nita; Evandro S Mello; Luiz Caetano da Silva; Venancio A F Alves; Flair J Carrilho
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

6.  Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.

Authors:  Michael Pavlides; Rajarshi Banerjee; Joanne Sellwood; Catherine J Kelly; Matthew D Robson; Jonathan C Booth; Jane Collier; Stefan Neubauer; Eleanor Barnes
Journal:  J Hepatol       Date:  2015-11-10       Impact factor: 25.083

7.  Fibrosis in Chronic Hepatitis C: Correlation between Immunohistochemically-Assessed Virus Load with Steatosis and Cellular Iron Content.

Authors:  Maha Akl; Ali El Hindawi; Maha Mosaad; Ahmed Montasser; Ahmed El Ray; Heba Khalil; Amgad Anas; Raffat Atta; Valerie Paradis; Ahmed Abdel Hadi; Olfat Hammam
Journal:  Open Access Maced J Med Sci       Date:  2016-11-15

8.  Retinol from hepatic stellate cells via STRA6 induces lipogenesis on hepatocytes during fibrosis.

Authors:  Injoo Hwang; Eun Ju Lee; Hyomin Park; Dodam Moon; Hyo-Soo Kim
Journal:  Cell Biosci       Date:  2021-01-06       Impact factor: 7.133

9.  Diagnostic and prognostic significance of hepatic steatosis in patients with chronic hepatitis C.

Authors:  Ionelia Sorina Stan; Viorel Biciuşcă; Patricia Durand; Ana Maria Petrescu; Dragoş Mihai Oancea; Alexandra Roxana Ciuciulete; Mihai Petrescu; Ion Udriştoiu; Georgiana Cristiana Camen; Mara Amalia Bălteanu; Cristina Maria Mărginean; Suzana Dănoiu
Journal:  Rom J Morphol Embryol       Date:  2021 Jul-Sep       Impact factor: 0.833

10.  Comparative diagnostic study of biomarkers using FibroMax™ and pathology for prediction of liver steatosis in patients with chronic hepatitis C virus infection: an Egyptian study.

Authors:  Ahmad Fouad; Dina Sabry; Rasha Ahmed; Manal Kamal; Sayed Abd Allah; Samar Marzouk; Mona Amin; Rokaya Abd El Aziz; Ahmad El Badri; Hany Khattab; Dina Helmy
Journal:  Int J Gen Med       Date:  2013-03-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.